CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 28, 2014		Mar. 29, 2013
Cash flows from operating activities:
Net earnings	$ 190,748		$ 208,071
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	18,640		23,391
Tax benefits from exercises of share-based payment awards	8,544		8,162
Excess tax benefits from share-based compensation	(8,482)		(7,503)
Depreciation	28,701		30,291
Amortization of intangible assets	1,938		2,215
Deferred taxes	(14,567)		3,714
Provision for doubtful accounts receivable	5,633		4,110
Loss on equity investment in affiliate	600		564
Other, net	(1,553)		(169)
Changes in assets and liabilities, net of effect of acquisition:
Accounts receivable	(99,465)		(49,532)
Inventories	(23,062)		(46,708)
Prepaid expenses and other assets	(5,354)		(21,344)
Accounts payable	(16,309)		(8,162)
Accrued expenses and other liabilities	45,074		(65,426)
Deferred revenues and advance payments from customers	38,027		20,842
Net cash provided by operating activities	169,113		102,516
Cash flows from investing activities:
Purchases of property, plant and equipment	(43,805)		(38,853)
Investment in corporate debt security	(13,746)		(4,610)
Net amounts received from deferred compensation plan trust account			400
Other	(1,356)		(296)
Net cash used in investing activities	(58,907)		(43,359)
Cash flows from financing activities:
Repurchases of common stock	(314,525)		(193,890)
Proceeds from issuance of common stock to employees	64,085		80,582
Excess tax benefits from share-based compensation	8,482		7,503
Employees' taxes withheld and paid for restricted stock and restricted stock units	(8,478)		(4,531)
Net borrowings under line of credit agreements			79,750
Repayments under term loan facility	(37,500)
Other	(408)		(25)
Net cash used in financing activities	(288,344)		(30,611)
Effects of exchange rate changes on cash and cash equivalents	(726)		6,617
Net increase/(decrease) in cash and cash equivalents	(178,864)		35,163
Cash and cash equivalents at beginning of period	1,117,861	[1]	704,570
Cash and cash equivalents at end of period	$ 938,997		$ 739,733

[1] The condensed consolidated balance sheet as of September 27, 2013 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.